Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Launching the Era of Melanoma Survivorship: Defining Benchmarks in Quality of Life Inclusive of Mental Health (QOL-MH)

NCT07379138 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07379138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Launching the Era of Melanoma Survivorship: Defining Benchmarks in Quality of Life Inclusive of Mental Health (QOL-MH)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
December 10, 2025
Completion date
December 31, 2031
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma